Skip to content
Use caution Drug recall · FDA · Published December 21, 2016

Teva Amoxicillin Recall: Subpotency Risk in 100 mL Bottles

Teva Pharmaceuticals recalls specific lots of Amoxicillin for Oral Suspension due to subpotency. Check your bottle's lot number and expiration date immediately.

🇺🇸 FDA recall #D-0440-2017DrugTeva ›
Take action

Contact the company

Recalling firmTeva Pharmaceuticals USA1090 Horsham Rd · North Wales, PA 19454-1505
✎ GovInfoNow plain-language explainer

What happened, in plain English

Teva Pharmaceuticals USA is recalling Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in 100 mL bottles because the medication may be subpotent. This issue stems from a low, out-of-specification test result for assay during stability testing. The recall affects 133,601 bottles distributed across the United States and Puerto Rico. Read more at govinfonow.com/recall/42111-teva-amoxicillin-recall-subpotency-risk-in-100-ml-bottles.

Source Summary by GovInfoNow · govinfonow.com/recall/42111-teva-amoxicillin-recall-subpotency-risk-in-100-ml-bottles · Updated October 11, 2026 · FDA enforcement record: FDA #D-0440-2017

Cite this page

“Teva Amoxicillin Recall: Subpotency Risk in 100 mL Bottles.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/42111-teva-amoxicillin-recall-subpotency-risk-in-100-ml-bottles. Based on FDA recall #D-0440-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0440-2017%22&limit=1).

Why it’s dangerous

The recalled product has a subpotency issue, meaning it contains less active ingredient than labeled due to failed stability testing. Taking subpotent antibiotics can lead to inadequate treatment of bacterial infections, potentially allowing the infection to persist or worsen.

Who’s affected

Patients who have been prescribed Amoxicillin for Oral Suspension by Teva Pharmaceuticals USA are affected. Individuals using the specific lots listed below are at risk of receiving medication that may not contain the full intended dose.

How to tell if you have this one

Check if you have Amoxicillin for Oral Suspension USP, 125 mg per 5 mL in a 100 mL bottle manufactured for TEVA PHARMACEUTICALS USA. Verify the NDC is 0093-4150-73 and the lot number is one of: 35432507A, 35434914A, 35435798A, or 35437490A. The expiration date on these bottles is 9/19.

  • Brand
    Teva
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your bottle matches the NDC 0093-4150-73 and has one of the recalled lot numbers with an expiration date of 9/19.

  2. Contact Your Pharmacist

    If you have a recalled bottle, contact your pharmacist or healthcare provider to discuss replacing the medication or obtaining a new prescription.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “United States and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 14 months after the firm started it.

1. Firm started the recall: Dec 21, 201612. FDA classified it Class II: Jan 24, 201723. Published in FDA’s Enforcement Report: Feb 1, 201734. FDA terminated the recall: Feb 6, 2018420162018
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the NDC number for the recalled product?

The National Drug Code (NDC) for the recalled product is 0093-4150-73.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0440-2017 (December 21, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0440-2017 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA